Is the Pharmacological Mode of Action of Chromium(III) as a Second Messenger?
Although recent studies have shown that chromium (as the trivalent ion) is not an essential trace element, it has been demonstrated to generate beneficial effects at pharmacologically relevant doses on insulin sensitivity and cholesterol levels of rodent models of insulin insensitivity, including models of type 2 diabetes. The mode of action of Cr(III) at a molecular level is still an area of active debate; however, the movement of Cr(III) in the body, particularly in response to changes in insulin concentration, suggests that Cr(III) could act as a second messenger, amplifying insulin signaling. The evidence for the pharmacological mechanism of Cr(III)’s ability to increase insulin sensitivity by acting as a second messenger is reviewed, and proposals for testing this hypothesis are described.
KeywordsChromium Second messenger Transferrin Insulin Low-molecular-weight chromium-binding substance
- 1.Vincent JB (2013) The bioinorganic chemistry of chromium. Wiley, ChichesterGoogle Scholar
- 2.EFSA Panel on Dietetic Products, Nutrition, and Allergies (2014) Scientific opinion on dietary reference values for chromium. EFSA J 12:3845Google Scholar
- 12.Ge D, Wu K, Cruce AA, Bowman MK, Vincent JB (2015) Binding of trivalent chromium to serum transferrin is sufficiently rapid to be physiologically relevant. J Inorg Biochem, in pressGoogle Scholar
- 15.Brock JH (1985) Transferrins. In: Harrison PM (ed) Metalloproteins, 2nd edn. Macmillan, London, pp 183–262Google Scholar
- 39.Panzhinskiy E, Ren J, Vincent JB, Sreejayan N (2012) A novel endogenous chromium binding peptide augments glucose uptake and insulin signaling in myotubes. Diabetes 61(1):A412Google Scholar
- 40.Chen G, Liu P, Pattar GR, Tackett L, Bhonagiri P, Strawbridge AB, Elmendorf JS (2006) Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Mol Endocrinol 20:857–870PubMedCrossRefGoogle Scholar
- 41.Horvath EM, Tackett L, McCarthy AM, Raman P, Brozinick JT, Elmendorf JS (2008) Antidiabetogenic effects of chromium mitigate hyperinsulinemia-induced cellular insulin resistance via correction of plasma membrane cholesterol imbalance. Mol Endocrinol 22:937–950PubMedCentralPubMedCrossRefGoogle Scholar